На этой неделе специалисты в области кардиометаболизма возглавят международную программу, цель которой — изучить новые исследования в области метаболических заболеваний, а также последние разработки, связанные с COVID-19.
Всемирный конгресс по инсулинорезистентности, диабету и сердечно-сосудистым заболеваниям (WCIRDC), которому уже 18 лет, представляет собой междисциплинарную программу CME, которая впервые проходит в интерактивном полностью виртуальном формате с четверга по воскресенье. Конгресс посвящен диабету, ожирению, липидам, сердечно-сосудистым заболеваниям и энергетическому балансу, связывая фундаментальные исследования с клинической практикой.
Источник: Adobe Stock.
Регистрация в этом году бесплатна, а четырехдневная конференция будет доступна по запросу в течение 90 дней. Каждая сессия будет сопровождаться живым интерактивным форматом вопросов и ответов.
Иегуда Хандельсман
“The congress is the premier global multidisciplinary meeting dedicated to metabolism, obesity, diabetes, lipids, hypertension, chronic kidney disease, cardiovascular disease, heart failure and nonalcoholic fatty liver disease,” Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, medical director and principal investigator of the Metabolic Institute of America in Tarzana, California, an Endocrine Today Editorial Board Member and conference chair, told Healio. “It is innovative and unique in addressing the interrelationship of the various metabolic disorders by international diverse faculty representing all related disciplines. It is the only conference of its size, which spans basic science to clinical practice.”
The program, Handelsman said, is designed to evaluate clinical and basic science aspects of diabetes, obesity, hypertension, dyslipidemia, heart failure, CVD, CKD and related cardiometabolic conditions by also focusing on insulin resistance, hyperinsulinemia, fat inflammation and energy metabolism. There are multiple interactive sessions focusing on state-of-the-art clinical management of diabetes, dyslipidemia, CKD and CVD. The goal is to understand the pathophysiology of each condition and develop appropriate, comprehensive clinical management plans, he said.
Handelsman said the strength of the meeting is its faculty, all leaders in their respective fields, who link basic research with clinical practice.
“Another unique feature of the conference in its pursuit of improved patients care is the incorporation of ‘implication to practice’ following all sessions, including basic science sessions,” Handelsman said.
The meeting also offers attendees the chance to network with global faculty in a virtual format, Handelsman said.
The congress offers several highlights this year:
A session on lipotoxicity Thursday at 8 a.m. PST will focus on the pathophysiologic link behind “cardiometabolic syndrome,” with Robert Chilton, DO, Ralph DeFronzo, MD, Kenneth Cusi, MD, and Eric Ravussin, PhD.
Also on Thursday, Martha Gulati, MD, Gina Lundberg, MD, and Howard Hodis, MD, will participate in a session on heart disease in women that explores sex differences on coronary artery calcium, sex-specific differences in risk factors for heart failure and estrogen replacement, atherosclerosis and CVD.
Загрузка...
